CartiHeal Raises $18.3 Million

CartiHeal closed a US $18.3MM financing round. Funds will support the recently-approved Investigational Device Exemption clinical trial of the Agili-C™ implant, in pursuit of a Premarket Approval.

The two-year pivotal U.S./ex-U.S. study seeks to demonstrate superiority of the Agili-C™ implant vs. surgical standard of care in the treatment of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us